Diaceutics approach is designed to assist pharmaceutical executives and management in strategically considering and operationalizing personalization, therapy targeting and companion diagnostic approaches within particular therapy areas.
Leveraging the unique capabilities of Case Based Reasoning (CBR) to research, Diaceutics has created a comprehensive mirror pathway for personalized medicine incorporating the standardized processes required to infuse into pharmaceutical research, development and lifecycle pathway.
The research design for every project is necessarily customized and Diaceutics collaborates closely with your team — initially using consultative techniques like Decision Analytics to frame your strategic business objectives within personalized medicine before helping the team devise the optimum plan and implementation strategy for therapy areas, individual therapies or total R&D and lifecycle strategies.
Installing A Standardized PM Planning Competence Across The Development and Commercial Model
For Clients requiring a joined up planning solution which standardizes and customizes the processes for personalized medicine across the pipeline and allows companies to build their own core competence in PM, Diaceutics has integrated the PM mirror pathway into a series of proprietary web applications called FUSION. FUSION augments the pharmaceutical model with a light touch planning and operational structure targeted at optimizing return on investment with the collaboration of all departments involved in developing and commercializing personalized medicine.
*Diaceutics services and products are subject to multiple US patent applications.